Search Results - "Damhofer, H."

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy by Veenstra, V. L., Damhofer, H., Waasdorp, C., van Rijssen, L. B., van de Vijver, M. J., Dijk, F., Wilmink, H. W., Besselink, M. G., Busch, O. R., Chang, D. K., Bailey, P. J., Biankin, A. V., Kocher, H. M., Medema, J. P., Li, J. S., Jiang, R., Pierce, D. W., van Laarhoven, H. W. M., Bijlsma, M. F.

“…Pancreatic ductal adenocarcinoma (PDAC) is characterized by abundant stroma that harbors tumor-promoting properties. No good biomarkers exist to monitor the…”
Get full text

Hedgehog-stimulated chemotaxis is mediated by smoothened located outside the primary cilium by Bijlsma, Maarten F, Damhofer, Helene, Roelink, Henk

“…Regulation of the Hedgehog (Hh) pathway relies on an interaction of two receptors. In the absence of Hh, Patched1 (Ptch1) inhibits the pathway. Binding of the…”
Get more information

Circulating levels of ADAM12, a stromal activation biomarker, are predictive of survival in pancreatic ductal adenocarcinoma (PDAC) by van Laarhoven, H.W., Damhofer, H., Veenstra, V.L., Waasdorp, C., van Rijssen, L.B., Dijk, F., Wilmink, J.W., Besselink, M.G., Busch, O.R., Medema, J.P., Shiansong Li, J., Jiang, R., Pierce, D.W., Bijlsma, M.F.

Get full text